Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Pioneer Pharma Holdings is a prominent pharmaceutical and medical device service provider focused on the marketing, promotion, and sale of imported healthcare products in China. The company acts as a vital bridge for international manufacturers, such as Alcon and Alfa Wassermann, to access the Chinese market across therapeutic areas including ophthalmology, cardiovascular, and pain management. Its portfolio features well-known brands like Difflam and Fluxum, alongside a range of medical devices and wound care solutions. While primarily a distribution and commercialization partner, the company also maintains manufacturing facilities and has recently diversified into the new energy sector. China Pioneer Pharma is listed on the Hong Kong Stock Exchange and operates an extensive nationwide sales network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Pioneer Pharma.